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INTRODUCTION
Although cerebrovascular diseases are rare in childhood,
moyamoya disease is a relatively important and common dis-
ease, especially among East Asian children. The pathophysi-
ology of the moyamoya disease is that of progressive narrow-
ing of the major medium- and/or large-sized cerebral arter-
ies; however, the cause of the arterial narrowing is not known.
Moyamoya disease was named for the abnormal vascular
network at the base of the brain that is typically found on
cerebral angiography (1). The disease was first reported by
Takeuchi and Shimizu in 1957 and the term ‘‘moyamoya’’
means ‘‘something hazy just like a puff of cigarette smoke
in the air’’ (1, 2).
In children, the disease generally presents as either tran-
sient ischemic attacks manifesting as a motor disturbance
(70 to 80%), or with epileptic seizures (20 to 30%) (3). Once
the diagnosis of moyamoya disease is suspected on clinical
evaluation, confirmation by neuroradiological studies follows.
Use of either invasive angiography or magnetic resonance
imaging (MRI) and magnetic resonance angiography (MRA)
are commonly employed for diagnosis (3, 4). The most con-
sistent finding on the neuroradiological examination is the
stenosis or occlusion of the terminal portion of the bilateral
internal carotid arteries that is associated with an abnormal
vascular network at the base of the brain. Therefore, several
test modalities, such as the single photon emission comput-
ed tomography (SPECT) or MRA, have been used for diag-
nosis (5-7). 
The electroencephalogram (EEG) is not commonly used
as a diagnostic tool for this disorder. The EEG findings asso-
ciated with moyamoya disease are high-amplitude slow waves,
called hemispheric posterior slowing or centrotemporal slow-
ing; these findings often appear in association with cerebral
ischemia (8). The characteristic EEG findings associated with
moyamoya have been reported to be a ‘‘build up’’ phenomenon,
that is, the appearance of monorhythmic generalized and
high voltage slow waves during hyperventilation followed
by the ‘‘re-build up’’ phenomenon, the reappearance of poly-
morphous high amplitude slow waves several minutes after
the end of hyperventilation (9, 10).
The aim of this study was to evaluate the usefulness of the
EEG as a follow-up test for the postoperative status of patients
with moyamoya disease. We studied the clinical characteris-
tics of patients who underwent surgical revascularization for
moyamoya disease and analyzed the correlationship among
clinical, EEG and SPECT findings before and after the sur-
gical procedure. 
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Postoperative Electroencephalogram for Follow up of Pediatric
Moyamoya Disease
It is well known that the electroencephalographic finding in patients with moyamoya
disease demonstrates the characteristic ‘‘re-build up’’ phenomenon a few minutes
after hyperventilation. To evaluate the usefulness of an electroencephalogram (EEG)
in the postoperative management of children with moyamoya disease, we studied
the presence or absence of improvement in the clinical, single photon emission
computed tomography (SPECT) and EEG findings, before and after surgery. Twen-
ty-two patients, who underwent indirect revascularization surgery for moyamoya
disease, were included in our study. Clinical improvement was assessed as the
disappearance or decrease of a transient ischemic attack or headache. The findings
on the EEG and SPECT were considered improved when the re-build up pheno-
menon was absent and when there was improvement in the cerebrovascular reserve
as a result of the acetazolamide challenge test. The statistical correlation analysis
for both clinical and EEG improvement were consistent (kappa value=0.409, p<0.05).
However, the result from the clinical and SPECT improvement as well as that from
EEG and SPECT improvement were not statistically significant. Our results suggest
that EEG can be used as a noninvasive and simple follow-up test for moyamoya
disease after indirect revascularization surgery if the hyperventilation procedure is
effectively performed during EEG recording.
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MATERIALS AND METHODS
A total of one hundred and thirteen patients below the age
of fifteen years-old underwent surgical revascularization at
the Asan Medical Center, Seoul, Korea from March 1995 to
March 2001. We reviewed the medical records and the patients
who did not have EEG data before and after the operation
were excluded from this study. As well, patients who did not
perform the effective hyperventilation during the EEG record-
ing were excluded. We defined effective hyperventilation on
the basis of the build up phenomenon or on the technician’s
electroencephalographic description. The patients with a mild
cerebral infarction on MRI or with continuous focal slowing
on the EEG were included. We recruited twenty-two patients
for this study. 
We performed the EEG or SPECT evaluations 6-12 months
after the surgery; clinical evaluation for the recurrence of sym-
ptoms was done every three months after the surgery. The
EEG was done on an international 10-20 system and was
recorded 2 to 5 min after hyperventilation for 3 min (Fig. 1).
We obtained SPECT images from the Triad XLT 20 (Trion-
ix, OH, U.S.A.) using the Tc-99m ethyl cysteinate dimer with
acetazolamide stress. 
Clinical improvement was defined as the decrease in fre-
quency or intensity of the TIAs or headache. Improvement
of EEG findings was based on the disappearance of the re-
build up phenomenon. Improvement on SPECT imaging
was defined by improvement in the cerebrovascular reserve
with acetazolamide stress test.
In order to evaluate the usefulness of the EEG as a follow-
up test for moyamoya disease, we used the kappa value for
statistical analysis. After indirect revascularization surgery
we compared various sets, which can consist of pairs out of




Patients presented initially with the following symptom
and sign: TIA (n=19), seizure (n=1), hemiplegia (n=1) and
headache (n=1). The ratio of male to female patients was 1:1.
The median age of the patients was six years old. The dura-
tion from the onset of symptoms to the operation ranged
from one month to nine years (median duration, 16 months).
Before the surgery, cerebral infarction was detected in 8 pati-
ents and associated with hydrocephalus in one case. One pati-
ent had a cerebral infarction after the first operation. The
follow-up duration ranged from 7 months to 60 months with
a median duration of 26 months (Table 1). Clinical improve-
Fig. 1. Preoperative electroencephalographic findings before and
after hyperventilation (11 yr old boy). (A) Before hyperventilation,
(B) At the end of hyperventilation and (C) 90 sec after hyperventi-
lation. The ‘‘re-build up’’ phenomenon is observed over the left hemi-
sphere after hyperventilation (C).
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ment was found in about 82% of patients. Improvement in
EEG and SPECT was about 68%, 73% respectively (Table 2).
Agreement among clinical, EEG and SPECT improvement
Based on the statistical analysis for clinical and EEG imp-
rovement, the kappa value was 0.409, which signifies good
agreement (p<0.05). In the case of clinical and SPECT imp-
rovement, there were poor agreement and no significant result.
In addition, agreement between the postoperative EEG and
SPECT improvement did not show statistical significance.
Out of four cases with no clinical improvement, three cases
showed no improvement in EEG findings, whereas there was
no SPECT improvement in one case. In seven cases of no
EEG improvement, SPECT improvement did not observed
in two cases.
DISCUSSION
Moyamoya disease was first reported by Takeuchi and Shi-
mizu (2). The disease is characterized by hypoplasia of the
bilateral internal carotid arteries. The abnormal vascular net-
work is found on angiography (1, 2). The prevalence of the
disease is high in East Asian countries, especially in Japan,
China and Korea. Although the etiology of moyamoya dis-
ease is still not known, it is considered to be multifactorial
condition that is affected by elements such as vascular growth
factors, cytokines, basic-fibroblast growth factor or genetic
abnormality (11-15).
In children, the disease generally presents with either fre-
quent TIAs manifesting as hemiparesis, monoparesis and/or
sensory disturbance (70 to 80%), or with epileptic seizures
(20 to 30%) (3). In addition, headache or involuntary move-
ments can also be a presenting symptom. In our study, hemi-
paresis was observed in about 86.4%; the presence of seizure
or headache was noted in a small number of patients.
The diagnosis of moyamoya disease can be confirmed by
conventional angiography or MRA; the findings from these
studies can be useful for planning surgical treatments (3, 4).
Cerebral blood flow is evaluated to determine the clinical
severity of moyamoya disease, the effectiveness of indirect
revascularization surgery and it can be measured by 133xenon
computed tomography, SPECT, or positron emission tomog-
raphy (5-7, 16, 17).
In children, EEG may provide definite information on
moyamoya disease even when clinical symptoms are miss-
ing (10). The EEG findings associated with moyamoya dis-
ease shows high-amplitude slow waves in association with
cerebral ischemia and the characteristic ‘‘re-build up’’ phe-
nomenon. A ‘‘re-build up’’ phenomenon is the reappearance
of polymorphous slow waves several minutes after cessation
of the hyperventilation (8-10). About 95% of all reported
cases where a hyperventilation test was performed during
EEG recording showed this ‘‘re-build up’’ phenomenon (10).
In this study we obtained the re-build up phenomenon in
about 80% of the patients who were capable of performing
an effective hyperventilation. When a patient presented with
seizure and characteristic EEG changes, moyamoya disease
was considered as a possible etiology.
The mechanism that is responsible for the EEG re-build
up phenomenon is still unclear, but several studies have sug-
gested a possible mechanism. Electrophysiological build-up
during hyperventilation is based on a reduction of the arte-
rial partial pressure of carbon dioxide as a result of hyperven-
tilation and the consequent reduction of cerebral perfusion
(18). The concentration of oxygenated hemoglobin progres-
sively increases during hyperventilation and subsequently
decreases after hyperventilation for 5 to 7 min. The re-build
up phenomenon occurs when oxygenated hemoglobin decreas-
es and the deoxygenated hemoglobin increases (19). In a
region where cerebrovascular reactivity is disturbed, a reduc-
tion of regional cerebral blood flow after hyperventilation
results. Therefore, the regional cerebral hypoxia and the dis-
turbance in oxygen metabolism play important roles in the
occurrence of the re-build up phenomenon after hyperventi-
lation (20, 21).
Surgical revascularization procedures are used to augment




Age at operation 4-15 yr
Chief complaint at first visit





Duration of symptom 1 month-9 yr (median, 16 months)
Cerebral infarction 8 (36.4%)
Abnormal EEG findings* 17 (77.2%)
Postoperative 
Follow-up period 7-60 months (median, 26 months)
Table 1. The clinical characteristics of patients with moyamoya
disease
EEG, electroencephalogram. *, Abnormal EEG findings included slow
wave discharges or re-build up phenomenon.
EEG, electroencephalogram; SPECT, single photon emission comput-
ed tomography.
No improvement Improvement
Clinical finding 4 18
EEG finding 7 15
SPECT finding 6 16
Table 2. The improvement in clinical, EEG and SPECT findings
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preferred for young children. Within a few months after
surgery, the ischemic attacks disappear in most patients (4).
Most patients included in this study had received the ence-
phaloduroarteriomyosynangiosis, which is known to be the
most effective procedure for preventing ischemic symptoms
in the middle- and anterior cerebral arteries in children with
moyamoya disease (22, 23).
After surgery for moyamoya disease, it is important to
follow patients for possible recurrence of symptoms associ-
ated with moyamoya disease because of progressive vascular
narrowing and ischemic insults. Moreover, because revascu-
larization surgery may prevent irreversible neuronal damage,
early detection of areas with impaired hemodynamics is crit-
ical in the management of moyamoya disease. It is also impor-
tant to evaluate whether there is the improvement of cere-
bral perfusion after the operation. Improved blood supply to
the ischemic brain from the external carotid artery branches
has been demonstrated. Determination of the correlation bet-
ween clinical outcome and the degree of revascularization
from surgery, as evaluated by neurological investigation, is
difficult (24). Therefore, effective methods to monitor the
change of regional cerebral perfusion reserve after surgery is
required. SPECT is valuable in assessing the cerebral perfu-
sion reserve and predicting a long-term prognosis, but the
procedure is somewhat inconvenient to perform in children.
Unlike SPECT, the EEG cannot directly reflect the blood per-
fusion or vascular reserve in cortical areas. However, the EEG
is a noninvasive diagnostic tool that is commonly used, and
well tolerated, in children. We performed EEG and SPECT
6-12 months after surgery. The postoperative EEG findings
showed the disappearance or the reduction in the duration
and distribution of the ‘‘re-build up’’ phenomenon; these find-
ings are consistent with other reports (9). We found that there
was good agreement between clinical and EEG improvement
using the kappa statistic and that EEG may be useful tool
for predicting the disappearance or recurrence of clinical sym-
ptoms in children with moyamoya disease. In conclusion,
we suggest that an EEG, a simple and noninvasive study,
may be useful as the primary follow-up test after surgery for
moyamoya disease in children.
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